HIGHLIGHTS
- who: Jong Han Lee et al. from the Department of Marine Bio and Medical Science, Hanseo University, Seosan have published the Article: Effect of BBT-877 novel inhibitor of ATX on mouse model of type diabetic nephropathy, in the Journal: (JOURNAL)
- what: The authors investigated the effect of BBT-877 a novel inhibitor of ATX on the pathogenesis of DN in a mouse model of streptozotocin (STZ)-induced diabetes. The study demonstrates that BBT-877 may reduce blood glucose levels and suppress the expression of inflammatory cytokines and fibrotic factors in the kidney, thereby improving . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.